Atlantic Union Bankshares’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.15M Sell
16,849
-7,644
-31% -$954K 0.04% 274
2025
Q4
$2.99M Sell
24,493
-1,834
-7% -$210K 0.06% 250
2025
Q3
$2.64M Sell
26,327
-3,502
-12% -$315K 0.05% 260
2025
Q2
$2.47M Buy
+29,829
New +$2.38M 0.06% 241

Other funds holding XBI

Atlantic Union Bankshares's XBI Position: Q1 2026 in Review

Atlantic Union Bankshares reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 31% in Q1 2026, selling an estimated $954K and leaving 16,849 shares worth $2.15M. The position accounts for 0.04% of the portfolio, ranked #274.

Atlantic Union Bankshares first reported a position in XBI in Q2 2025 and has held it in 4 quarters since. The position peaked at $2.99M in Q4 2025. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • Atlantic Union Bankshares held 16,849 shares of State Street SPDR S&P Biotech ETF worth $2.15M as of Q1 2026.
  • Atlantic Union Bankshares sold 7,644 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $954K.
  • State Street SPDR S&P Biotech ETF made up 0.04% of Atlantic Union Bankshares's portfolio in Q1 2026, its #274 holding.
  • Atlantic Union Bankshares first reported a position in State Street SPDR S&P Biotech ETF in Q2 2025 and has held it in 4 quarters since.
  • Atlantic Union Bankshares's State Street SPDR S&P Biotech ETF position peaked at $2.99M in Q4 2025.
  • 814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Atlantic Union Bankshares's 13F filing for Q1 2026, filed 12 May 2026.